Stevanato Group’s (STVN) Core Business Improved Despite 22% Pullback in Q4
TimesSquare Capital Managementan equity investment management company, has released its “US Small Cap Growth Strategy” for investors for the fourth quarter of 2025. A copy of the book can be downloaded here. The strategy returned 3.70% (gross) and 3.45% (net) in the fourth quarter compared to a 1.22% return for the Russell 2000 Growth Index. By 2025, the strategy has returned 6.91% (gross) and 5.85% (net) compared to 13.01% for the index. Global Equity markets ended the quarter on a positive note, with Europe leading the way, followed by Emerging Markets. In most markets, large caps outperformed small caps. The trade agreement between the United States and China was extended for an additional year, but global concerns, whether related to tariffs or not, continued. Third-quarter GDP beat expectations, but consumer caution remains amid continued softening of the labor market, which has implications for the Fed’s decision to cut interest rates. Please review the top five Strategy items for details on your key choices for 2025.
In its fourth quarter 2025 investor note, TimesSquare Capital US Small Cap Growth Strategy highlighted stocks like Stevanato Group SpA (NYSE:STVN). Stevanato Group SpA (NYSE:STVN) designs and distributes products and processes to provide integrated solutions for the biopharma and healthcare industries. On March 31, 2026, Stevanato Group SpA (NYSE:STVN) closed at $13.75 per share. Stevanato Group SpA (NYSE:STVN)’s one-month return was -20.26%, and its shares lost 33.45% in the last 52 weeks. Stevanato Group SpA (NYSE:STVN) has a market capitalization of about $3.81 billion.
TimesSquare Capital US Small Cap Growth Strategy said the following about Stevanato Group SpA (NYSE:STVN) in its fourth quarter 2025 investor note:
“The 22% return was Company Stevanato Group SA (NYSE:STVN), which produces glass packaging for syringes, autoinjectors, and other pharmaceutical applications. The latest revenue and profit each exceeded expectations, although management was unchanged and merely confirmed its guidance for the balance of the financial year. There may have been increased purchases from customers, although Stevanato’s business has grown well, and we are adding to our weak position. “
Stevanato Group SpA (NYSE:STVN) is not on our list of the 40 Most Popular Stocks Among Hedge Funds Entering 2026. According to our data, 15 hedge fund portfolios held Stevanato Group SpA (NYSE:STVN) at the end of the fourth quarter, up from 13 last quarter. In Q4 2025, Stevanato Group SpA (NYSE:STVN) revenue grew 7% on a constant currency basis and 5% on a reported basis to $346.5 million. While we recognize the potential of Stevanato Group SpA (NYSE:STVN) as an investment, we believe certain AI stocks offer greater potential and carry less downside risk. If you’re looking for an extremely overlooked AI stock that will benefit greatly from the Trump-era costs and sea trend, check out our free report best short term AI stock.
